Extrahepatic manifestation like fever, ahralgia, rash and eosinophilia is typically seen with which type drug induced liver injury?
Wait, the user provided the correct answer as "C." but the options are missing. How can I proceed? Maybe I need to infer the options based on common DILI types. Drug-induced liver injury (DILI) can be hepatocellular, cholestatic, or mixed. Extrahepatic manifestations like fever, myalgia, rash, and eosinophilia are typically associated with a specific type. Let me recall. These symptoms are often seen in immune-mediated DILI, which is more likely to present with a hypersensitivity reaction. The cholestatic type might have pruritus but not the systemic symptoms. Hepatocellular injury is more about elevated ALT/AST. The mixed type would have both. But the extrahepatic features are classic for a hypersensitivity reaction, which is more common in certain drugs like anti-epileptics or some antibiotics.
Wait, the question is about the type of DILI. The types are usually categorized as hepatocellular, cholestatic, or mixed. But there's also a classification based on mechanism: intrinsic (predictable, dose-dependent) vs. idiosyncratic (unpredictable, immune-mediated). The extrahepatic features like fever and rash are more characteristic of idiosyncratic DILI, which is often immune-mediated. However, the question is about the type of DILI based on liver injury pattern. The options might be hepatocellular, cholestatic, mixed, and another type. Let me think. For example, if the options are A: Hepatocellular, B: Cholestatic, C: Mixed, D: Autoimmune-like. The correct answer would be C: Mixed? Or maybe the answer is hepatocellular. Wait, I need to be precise.
Wait, the core concept here is that extrahepatic manifestations (fever, rash, eosinophilia) are more common in immune-mediated DILI, which is often associated with a mixed pattern of liver injury. So if the options are hepatocellular, cholestatic, mixed, and another, the correct answer would be mixed. That's a high-yield point for exams. So if the correct answer is C, then the options must be structured accordingly.
So, putting it all together: the core concept is that immune-mediated DILI presents with extrahepatic features and a mixed pattern. The correct answer is mixed. The wrong options would be hepatocellular, cholestatic, and maybe another like intrinsic. The clinical pearl is that mixed DILI is linked to immune reactions and systemic symptoms.
Now, I need to structure the explanation accordingly, making sure to explain why the correct answer is right (mixed DILI), and why the others are incorrect. Also, mention the clinical pearl about immune-mediated reactions causing systemic symptoms.
**Core Concept